+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunoglobulin Product Market Research Report by Type (IGA, IGD, and IGE), ROA, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904902
  • Report
  • April 2022
  • Region: Global
  • 208 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Baxter International Inc.
  • Beckman Coulter Inc.
  • CSL Limited
  • F. Hoffmann-La Roche AG
  • Immunos Therapeutics
  • Kedrion Biopharma
The Global Immunoglobulin Product Market size was estimated at USD 10,166.78 million in 2020, USD 11,292.24 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.93% to reach USD 18,949.88 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Immunoglobulin Product to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across IGA, IGD, IGE, IGG, and IGM.
  • Based on ROA, the market was studied across IMIG, IVIG, and SCIG.
  • Based on Application, the market was studied across CIDP, CLL, Congenital AIDS, Hypogammaglobulinemia, ITP, Immunodeficiency Diseases, Kawasaki Disease, Multifocal Motor Neuropathy, and Myasthenia Gravis.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Immunoglobulin Product Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Immunoglobulin Product Market, including Baxter International Inc., Bayer AG, Beckman Coulter Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Emergent BioSolutions Inc., Evolve Biologics Inc., F. Hoffmann-La Roche AG, GigaGen, Inc., Immunos Therapeutics, Kamada Ltd., Kedrion Biopharma, LFB group, Octapharma AG, Sanquin Plasma Products B.V., and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Immunoglobulin Product Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoglobulin Product Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoglobulin Product Market?
4. What is the competitive strategic window for opportunities in the Global Immunoglobulin Product Market?
5. What are the technology trends and regulatory frameworks in the Global Immunoglobulin Product Market?
6. What is the market share of the leading vendors in the Global Immunoglobulin Product Market?
7. What modes and strategic moves are considered suitable for entering the Global Immunoglobulin Product Market?
Frequently Asked Questions about the Global Immunoglobulin Product Market

What is the estimated value of the Global Immunoglobulin Product Market?

The Global Immunoglobulin Product Market was estimated to be valued at $10166.8 Million in 2020.

What is the growth rate of the Global Immunoglobulin Product Market?

The growth rate of the Global Immunoglobulin Product Market is 10.9%, with an estimated value of $18949.9 Million by 2026.

What is the forecasted size of the Global Immunoglobulin Product Market?

The Global Immunoglobulin Product Market is estimated to be worth $18949.9 Million by 2026.

Who are the key companies in the Global Immunoglobulin Product Market?

Key companies in the Global Immunoglobulin Product Market include Baxter International Inc., Bayer AG, Beckman Coulter Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Emergent BioSolutions Inc. and F. Hoffmann.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter International Inc.
  • Beckman Coulter Inc.
  • CSL Limited
  • F. Hoffmann-La Roche AG
  • Immunos Therapeutics
  • Kedrion Biopharma

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the Cases of Immunodeficiency Diseases
5.1.1.2. Growing Geriatric Population Around the World
5.1.1.3. Surge in the Adoption of Immunoglobulin Products
5.1.2. Restraints
5.1.2.1. High Cost and Adverse Effects of the Immunoglobulin Products
5.1.3. Opportunities
5.1.3.1. Ongoing Research and Development Activities in the Immunoglobulin
5.1.3.2. Introduction of New & Advanced Immunoglobulin Products
5.1.4. Challenges
5.1.4.1. Strict Rules and Norms of Governing Bodies for Product Approval
5.2. Cumulative Impact of COVID-19
6. Immunoglobulin Product Market, by Type
6.1. Introduction
6.2. IGA
6.3. IGD
6.4. IGE
6.5. IGG
6.6. IGM
7. Immunoglobulin Product Market, by ROA
7.1. Introduction
7.2. IMIG
7.3. IVIG
7.4. SCIG
8. Immunoglobulin Product Market, by Application
8.1. Introduction
8.2. CIDP
8.3. CLL
8.4. Congenital AIDS
8.5. Hypogammaglobulinemia
8.6. ITP
8.7. Immunodeficiency Diseases
8.8. Kawasaki Disease
8.9. Multifocal Motor Neuropathy
8.10. Myasthenia Gravis
9. Americas Immunoglobulin Product Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Immunoglobulin Product Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Immunoglobulin Product Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Baxter International Inc.
13.2. Bayer AG
13.3. Beckman Coulter Inc.
13.4. Bio Products Laboratory Ltd.
13.5. Biotest AG
13.6. China Biologic Products Holdings, Inc.
13.7. CSL Limited
13.8. Emergent BioSolutions Inc.
13.9. Evolve Biologics Inc.
13.10. F. Hoffmann-La Roche AG
13.11. GigaGen, Inc.
13.12. Immunos Therapeutics
13.13. Kamada Ltd.
13.14. Kedrion Biopharma
13.15. LFB group
13.16. Octapharma AG
13.17. Sanquin Plasma Products B.V.
13.18. Takeda Pharmaceutical Company Limited
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: DYNAMICS
FIGURE 2. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 3. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2026
FIGURE 5. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2020 VS 2026 (%)
FIGURE 16. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2026
FIGURE 18. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 25. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2026
FIGURE 27. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IMMUNOGLOBULIN PRODUCT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2018-2026 (USD MILLION)
TABLE 47. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY STATE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2018-2026 (USD MILLION)
TABLE 52. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 53. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY STATE, 2018-2026 (USD MILLION)
TABLE 54. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 56. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2018-2026 (USD MILLION)
TABLE 57. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 58. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 59. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 62. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 63. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY STATE, 2018-2026 (USD MILLION)
TABLE 64. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 66. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2018-2026 (USD MILLION)
TABLE 67. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 68. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY STATE, 2018-2026 (USD MILLION)
TABLE 69. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 71. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 72. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 73. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 74. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 76. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 77. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 78. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 79. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 81. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2018-2026 (USD MILLION)
TABLE 82. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 83. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 84. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 86. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 87. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 88. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 89. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 91. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 92. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 93. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 94. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 95. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 96. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 97. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 98. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 99. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 100. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 101. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 102. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 103. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 104. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 105. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 106. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 107. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 108. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 110. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 111. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 112. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 113. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 114. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 115. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 116. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 117. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 118. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 120. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 121. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: SCORES
TABLE 122. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: BUSINESS STRATEGY
TABLE 123. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: PRODUCT SATISFACTION
TABLE 124. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: RANKING
TABLE 125. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 126. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: MERGER & ACQUISITION
TABLE 127. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: INVESTMENT & FUNDING
TABLE 130. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Baxter International Inc.
  • Bayer AG
  • Beckman Coulter Inc.
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Evolve Biologics Inc.
  • F. Hoffmann-La Roche AG
  • GigaGen, Inc.
  • Immunos Therapeutics
  • Kamada Ltd.
  • Kedrion Biopharma
  • LFB group
  • Octapharma AG
  • Sanquin Plasma Products B.V.
  • Takeda Pharmaceutical Company Limited
Note: Product cover images may vary from those shown

Loading
LOADING...